Plain-English translation of NCT07540026 on ClinicalTrials.gov ↗ ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether two medications—sucralfate and tranexamic acid—can help stop bleeding from upper digestive tract tumors more effectively than alone. In this study, some patients will receive the usual treatments (injections, clips, and heat), while others will also have these two powders applied directly to the bleeding site during the endoscopy procedure. Researchers want to see if adding these medications improves outcomes.
Bleeding from stomach and esophageal tumors is hard to control because cancer erodes blood vessels, causing dangerous bleeding. Standard treatments help, but doctors are looking for ways to improve success rates and prevent bleeding from coming back.
You likely qualify if…
You likely don't qualify if…
You will have an upper endoscopy procedure where a doctor uses a camera to see and treat your bleeding tumor. All patients receive standard care (injection, clips, or heat treatment). If you are in the intervention group, the doctor will also apply two powders—sucralfate and tranexamic acid—directly onto the bleeding site. The procedure is done during one visit, and the study will track whether your bleeding stops and stays stopped.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Taiwan